| Term 
 
        | What are structural characteristics of fluoroquinolones? |  | Definition 
 
        | (Derived from parent quinolone, nalidixic acid)   Two fused six-membered rings with nitrogen; know that the fluoride increases potency (vs. quinolones) 
 [image] 
 Note: Quinolones (no fluoride) have good Gram- activity and no aminoglycoside-like toxicity, but it is easy to develop resistance against them. |  | 
        |  | 
        
        | Term 
 
        | What are common fluoroquinolones? |  | Definition 
 
        | Cipro-, levo-, gemifloxacin Note: Cipro exhibits post-antibiotic effect has particularly good penetration of bronchil/lung tissue, and is a good choice for respiratory infections. 
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Binds DNA coiling enzymes, inducing double-stranded DNA breaks. 
 DNA gyrase (primary target in Gram-) and topoisomerase IV (primary target in Gram+) relax positive supercoils in replicating DNA. Quinolones bind to these enzymes and inhibit re-ligation after the double-stranded nick. |  | 
        |  | 
        
        | Term 
 
        | Are quinolones bacteriostatic or bactericidal? |  | Definition 
 
        | Bactericidal. (Double-stranded DNA breaks always kill cell.) |  | 
        |  | 
        
        | Term 
 
        | What are mechanisms of resistance to quinolones? |  | Definition 
 
        | 1. Efflux: Upregulation of pre-existing transporters that use H+ motor force to pump out drug.  Note: In Gram= bacteria, pumps can efflux many drugs. In Gram+ organisms, pumps are selective for fluoroquinolones. 
 2. Mutation of topoisomerases prevents quinolone binding.  Note: Mutation in a single topoisomerase (DNA gyrase or topoisomerase IV) will confer intermediate-level resistance; mutation in both is needed for high-level resistance. |  | 
        |  | 
        
        | Term 
 
        | How are fluoroquinolones administered and distributed? |  | Definition 
 
        | Good oral bioavilability (70%). Note: Di- and trivalent cations decrease absorption (don't take with milk/antacid) 
 Wide distribution to most tissues and body fluids; variable CSF penetration. |  | 
        |  | 
        
        | Term 
 
        | How are fluoroquinolones metabolized and excreted? |  | Definition 
 
        | Predominantly cleared renally, though some are metabolized in liver and cleared through bile. |  | 
        |  | 
        
        | Term 
 
        | What are targets of fluoroquinolones? |  | Definition 
 
        | Classic target is Gram-, but also some activity against Gram+ (E. coli UTI), atypticals/intracellular (e.g. C. pneumoniae). Poor activity against anaerobes. |  | 
        |  | 
        
        | Term 
 
        | What are clinical uses of fluroquinolones? |  | Definition 
 
        | 1. UTIs (E. coli, S. saprophyticus).  2. Respiratory infections (H. influenezae, M. pneumoniae) Note: Very good penetration of bronchial mucosa and lung 3. Bacterial diarrheas 4. Osteomyelitis: penetrates bone. |  | 
        |  | 
        
        | Term 
 
        | What are adverse effects of fluoroquinolones? |  | Definition 
 
        | Relatively safe, but some GI irritation and CNS effects (headache, dizziness), photosensitivity.   Unique to fluororquinolones: Tendinitis, which can lead to tendon rupture (usually achilles) Damages growing cartilage Note: Contraindicated in children 
 
 |  | 
        |  | 
        
        | Term 
 
        | Who may not take quinolones? |  | Definition 
 
        | Children;and pregnant women quinolones can damage growing cartilage. Note: Not absolutely contraindicated if there are no alternatives. |  | 
        |  |